ImmunoPrecise Antibodies Ltd

TQB

Company Profile

  • Business description

    ImmunoPrecise Antibodies Ltd is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. IPA has several subsidiaries in North America and Europe.

  • Contact

    Industrious 823 Congress Avenue
    Suite 300
    AustinTX78701
    USA

    https://www.ipatherapeutics.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 April 2026

    Employees

    101

Stocks News & Analysis

stocks

Undervalued ASX share showing progress in global efforts

More clarity on the path forward in the UK.
stocks

Bookworm: Is this the secret to exceptional long-term returns?

Acceptance may be an investor’s best friend.
stocks

Unconventional wisdom: Are dividends the answers?

As investors toil in complexity the obvious solution may be the right one.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,963.5029.200.33%
CAC 407,925.5490.961.16%
DAX 4024,436.09218.590.90%
Dow JONES (US)44,901.92208.010.47%
FTSE 1009,164.8544.540.49%
HKSE25,588.18199.830.79%
NASDAQ21,108.3250.360.24%
Nikkei 22540,998.27457.96-1.10%
NZX 50 Index12,910.7457.280.45%
S&P 5006,388.6425.290.40%
S&P/ASX 2008,697.7030.800.36%
SSE Composite Index3,597.944.280.12%

Market Movers